About this episode
There are now two fully approved drugs on the market that can, sometimes, slow down the progression of Alzheimer's disease. Both have been shown to slow down the mental decline of Alzheimer's by more than 25%. But that's in a group of patients—an individual may do much better, or not be helped at all. NPR Science Correspondent Jon Hamilton has been talking to people who've taken these drugs. Today he has the story of two patients to receive them.
Interested in more human health stories? Contact us at [email protected].
Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
Interested in more human health stories? Contact us at [email protected].
Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
Get every episode summarized
Each time Short Wave publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Short Wave
A new investigation shows heat is even deadlier than we thought
Short Wave
Sep 4, 202614:45completed
The science of emotional regulation — and how to do it better
Short Wave
Sep 2, 202612:29pending
What can seashells teach us about the health of our oceans?
Short Wave
Sep 1, 202613:10pending
Football is here – and so is a new study on CTE
Short Wave
Aug 31, 202615:01pending